These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8093812)

  • 1. V-erbA requires auxiliary proteins for dominant negative activity.
    Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
    Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
    Wahlström GM; Harbers M; Vennström B
    Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C; Gibson L; Beug H
    Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
    Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
    Rascle A; Ghysdael J; Samarut J
    Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C; Gibson L; Zenke M; Beug H
    Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
    Wahlström GM; Vennström B
    Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
    Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
    Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibition.
    Meier-Heusler SC; Zhu X; Juge-Aubry C; Pernin A; Burger AG; Cheng SY; Meier CA
    Mol Cell Endocrinol; 1995 Jan; 107(1):55-66. PubMed ID: 7796935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimerization of v-erbA on inverted repeats.
    Zubkova I; Subauste JS
    Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
    Sharif M; Privalsky ML
    Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae.
    Smit-McBride Z; Privalsky ML
    Oncogene; 1993 Jun; 8(6):1465-75. PubMed ID: 8099219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of v-erbA homodimers and heterodimers in mediating dominant negative activity by v-erbA.
    Yen PM; Ikeda M; Brubaker JH; Forgione M; Sugawara A; Chin WW
    J Biol Chem; 1994 Jan; 269(2):903-9. PubMed ID: 7904604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.
    Chen HW; Privalsky ML
    Mol Cell Biol; 1993 Oct; 13(10):5970-80. PubMed ID: 8105369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
    Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
    Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the thyroid hormone response element in the skeletal alpha-actin gene: negative regulation of T3 receptor binding by the retinoid X receptor.
    Muscat GE; Griggs R; Downes M; Emery J
    Cell Growth Differ; 1993 Apr; 4(4):269-79. PubMed ID: 8388243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation?
    Ghysdael J; Beug H
    Cancer Surv; 1992; 14():169-80. PubMed ID: 1358441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potency.
    Meier CA; Parkison C; Chen A; Ashizawa K; Meier-Heusler SC; Muchmore P; Cheng SY; Weintraub BD
    J Clin Invest; 1993 Oct; 92(4):1986-93. PubMed ID: 8408652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interaction between the two zinc finger domains of the v-erb A oncoprotein.
    Hall BL; Bonde BG; Judelson C; Privalsky ML
    Cell Growth Differ; 1992 Apr; 3(4):207-16. PubMed ID: 1355356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
    Harbers M; Wahlström GM; Vennström B
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.